Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload

Published:2024-01-02 Issue:1 Volume:48 Page:47-55
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Chuansumrit Ampaiwan¹^ORCID,Songdej Duantida¹^ORCID,Sirachainan Nongnuch¹^ORCID,Kadegasem Praguywan¹^ORCID,Saisawat Pawaree¹^ORCID,Sungkarat Witaya²^ORCID,Kempka Ketsuda¹^ORCID,Tungbubpha Noppawan¹^ORCID

Affiliation:

1. Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

2. Department of Radiology and Advanced Diagnostic Image Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03630269.2024.2311360

Reference30 articles.

1. Schnall SF, Benz JEJ. Abnormalities of hemoglobin. In: Mazza JJ, editor. Manual of Clinical Hematology. Boston (MA): Marshfield; 1998. p. 118–122.

2. Hemoglobin E-β-Thalassemia: Progress Report from the International Study Group

3. Severity differences in β-thalassaemia/haemoglobin E syndromes: implication of genetic factors

4. Comprehensive management for thalassemia;Viprakast V.;J Hematol Transf Med,2013

5. Deferiprone (GPO-L-ONE®) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP